Phase I study of triple drug combination of CPT-11 (C), Oxaliplatin (O) and Tomudex (T) (COT) in previously untreated metastatic colorectal cancer (MCRC): National Cancer Institute of Canada Clinical Trials Group (NCIC CTG), IND.135

✍ Scribed by Maroun, J.A.; Jonker, D.; Seymour, L.; Goel, R.; Kocha, W.; Fisher, B.

• Book ID: 123343684
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 206 KB
• Volume: 37
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(01)81580-X